7Sconce EA, Khan TI, Wynne HA, et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient char- acteristics upon warfarin dose requirements: proposal for a new dosing regimen[J]. Blood,2005,106, 2329-2333.
8Biss TT, Kamali F. Warfarin anticoagulation in children: is there a role for a personalized approach to dosing? [J]. Phar- macogenomics, 2012,13( 11 ), 1211-1214.
9Streif W,Andrew M,Marzinotto V,etal. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients[J]. Blood, 1999,94 (9) :3007-3014.
10McDonald MG, Au NT, Wittkowsky AK, et al. Warfarin- amiodarone drug-drug interactions: determination of[I] (u)/K (I,u) for amiodarone and its plasma metabolites[J]. Clin Pharmacol Ther,2012,91 (4) :709-717.